MassDevice.com‘s editorial team put their heads together and came up with a list of the 5 most significant stories to cross the medical device space in 2015:
1. Mergers & acquisitions run rampant
This year began with the closing of the largest medtech merger in history: Medtronic’s $50 billion acquisition of Covidien. The deal was notable not just because of its size; it allowed Medtronic to reincorporate in Ireland, freeing billions in cash the Fridley, Minn.-based company pledged to use in part on acquisitions.Medtronic went on to fulfill that promise with a billion-dollar buying spree, paying $110 million for Aircraft Medical; $235 million for RF Surgical Systems; $110 million for Aptus Endosystems; $93 million for CardioInsight Technologies; $458 million for Twelve Inc.; $150 million for Medina Medical; $100 million for Lazarus Effect; an unspecified amount for Sophono; and took out unspecified stakes in Arsenal Medical subsidiary Arsenal AAA, Semma Therapeutics and Glooko. If you’re keeping score at home, that amounts to an M&A spend of at least $1.26 billion, excluding the Covidien deal. Consolidation was the name of the game across all tiers of the medical device space, from small contract manufacturing all the way to unions valued in the billions. A few notable transactions included:
- Greatbatch (NYSE:GB) pays $1.73 billion for OEM medical device maker Lake Region Medical.
- Pfizer (NYSE:PFE) agrees to pay $160 billion for Allergan (NYSE: AGN).
- St. Jude Medical (NYSE:STJ) pays $3.3 billion for Thoratec.
- Cardinal Health (NYSE:CAH) pays $1.94 billion for Johnson & Johnson’s (NYSE:JNJ)’s Cordis stent-making arm.
- Wright Medical (NSDQ:WMGI) and Tornier (NSDQ:TRNX) ink $3.3 merger-of-equals.
- Hill-Rom (NYSE:HRC) pays $2.05 billion for Welch Allyn.
- Dentsply International (NSDQ:XRAY) and Sirona Dental Systems (NSDQ:SIRO) ink an all-stock deal worth $5.56 billion.
- Pfizer (NYSE:PFE) pays $15 billion for Hospira.
- Boston Scientific (NYSE:BSX) pays $1.6 billion to buy the American Medical Systems urology biz from Endo Health Solutions.
- Four things every emerging medtech should know about M&A.